This is the fourth authorized indication in Europe for Reblozyl, a first-in-class treatment for patients with disease-related anemia
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
The slogan for this year's World Blood Donor Day campaign is 'Give blood, give plasma, share life, share often'
Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
Subscribe To Our Newsletter & Stay Updated
